InspireMD (NSPR) Misses Q2 EPS by 3c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/23/2026
- Nasdaq reaches record high close, AI stocks rally
- Meta AI agent triggers heavy selloff in banks, insurers, and travel stocks
- Exclusive: SB Energy Nasdaq IPO moving forward as planned
- AI and earnings keep driving markets as focus shifts to Trump-Xi summit
- Meta bull case increasingly playing out, Mizuho says
InspireMD Reports Financial Results for the First Quarter Ended March 31, 2015
May 11, 2015 8:01 AM EDTBOSTON, May 11, 2015 /PRNewswire/ --Â InspireMD, Inc. (NYSE MKT: NSPR) ("InspireMD" or the "Company"), a leader in stent embolic protection systems ("EPS"), today announced its financial and operating results for the first quarter ended March 31, 2015.
Alan Milinazzo, CEO of InspireMD, commented, "The first quarter marked the beginning of our full shift in activities towards our new strategy. We began positive early commercialization of the CGuard Rapid Exchange system, while completing our salesforce reorganization to a distributor model.  Importantly,... More
